Mount Vernon consultant recognised nationally for research excellence

The NHS National Institute for Health Research Clinical Research Network has recognised formally the contribution made to cancer research and development by Dr Paul Nathan, a consultant medical oncologist based at the Mount Vernon Cancer Centre.

Paul Nathan and research team colleagues

On learning of the announcement, Dr Nathan said:

“The melanoma/renal unit has the largest commercial trial portfolio within the cancer centre. We compete with units internationally to secure these studies, which are often early phase clinical trials of the most promising investigational treatments. This means that we are able to offer our patients potential access to the most innovative medicines.

“This recognition from the NHS National Institute for Health Research reflects the fact that we have a fabulous research nursing team with Ange Smith and Yolanda Kennedy who provide the highest possible standards of care for our patients, as well as the great R&D support we received – led by Rishma Bhatti and Jo Pascoe – that supports timely study opening and high quality data reporting.”

The Trust’s chief executive, Nick Carver, said:

“The Trust has a very strong research base, particularly at the Mount Vernon Cancer Centre. Dr Nathan is one of several senior consultants conducting trials of international importance and this recognition by the NHS National Institute for Health Research is a fitting tribute to him and his colleagues.”